ICOSLG-mediated regulatory T cell expansion and IL-10 production promote progression of glioblastoma

Abstract

Inhibition of the ICOSLG-inducible co-stimulator axis in GBM may provide a promising immunotherapeutic approach for suppressing a subset of GBM with an elevated mesenchymal signature.